Works matching IS 02770008 AND DT 2023 AND VI 43 AND IP 3

Results: 10

Novel and replicated clinical and genetic risk factors for toxicity from high‐dose methotrexate in pediatric acute lymphoblastic leukemia.

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 205, doi. 10.1002/phar.2779

By:

Zobeck, Mark;
Bernhardt, M. Brooke;
Kamdar, Kala Y.;
Rabin, Karen R.;
Lupo, Philip J.;
Scheurer, Michael E.

Publication type:

Article

Prospective, randomized, controlled, trial to assess ASADOSing by body mass index in HEalthy volunteers (DOSE study).

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 215, doi. 10.1002/phar.2777

By:

Nay, Isaac;
Hutchinson, Doug;
Rondina, Matthew;
Kim, Kibum;
Kroencke, Rachel;
Kirkham, Amanda;
Trujillo, Toby;
Tolley, Neal D.;
Munger, Mark

Publication type:

Article

Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation.

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 196, doi. 10.1002/phar.2776

By:

Buckley, Mitchell S.;
Benanti, Grace E.;
Meckel, Jordan;
Tekle, Luwam A.;
Gilbert, Brian;
Puebla Neira, Daniel;
McNierney, Dakota A.;
Korkames, Grace;
Yerondopoulos, Melanie;
Park, Andrew;
O'Hea, Jennifer A.;
MacLaren, Robert

Publication type:

Article

Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction.

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 247, doi. 10.1002/phar.2775

By:

Caniff, Kaylee E.;
Rebold, Nicholas;
Rybak, Michael J.

Publication type:

Article

Critique of "Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality".

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 257, doi. 10.1002/phar.2773

By:

Her, Qoua L.;
Dhopeshwarkar, Neil;
Feeney, Timothy

Publication type:

Article

Authors response to critique of "angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality".

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 259, doi. 10.1002/phar.2772

By:

Alexander, Donald P.;
Nickman, Nancy A.;
Chhibber, Anindit;
Stoddard, Gregory;
Biskupiak, Joseph E.;
Munger, Mark A.

Publication type:

Article

Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy.

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 180, doi. 10.1002/phar.2771

By:

Wang, Chuhui;
Chen, Jiaojiao;
Yang, Bo;
Li, Sihan;
Zhang, Yiran;
Chen, Lei;
Wang, Taotao;
Dong, Yalin

Publication type:

Article

Impact of pre‐lung transplant statin use on the development of primary graft dysfunction.

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 189, doi. 10.1002/phar.2770

By:

Yuenger, Valerie;
January, Spenser;
Fester, Keith;
McCloskey, Michele;
Hachem, Ramsey

Publication type:

Article

Comprehensive guidance for antibiotic dosing in obese adults: 2022 update.

Published in:

Pharmacotherapy, 2023, v. 43, n. 3, p. 226, doi. 10.1002/phar.2769

By:

Meng, Lina;
Mui, Emily;
Ha, David R.;
Stave, Christopher;
Deresinski, Stan C.;
Holubar, Marisa

Publication type:

Article

Issue Information.

Published in:: Pharmacotherapy, 2023, v. 43, n. 3, p. 177, doi. 10.1002/phar.2550
Publication type:: Article